Association of HLA-G low expressor genotype with severe acute graft-versus-host disease after sibling bone marrow transplantation

Frontiers in Immunology

Volumn 2, Issue DEC, 2011, Pages

  Boukouaci, Wahid ^a   Busson, Marc ^a   Fortier, Catherine ^a   Amokrane, Kahina ^a   De Latour, Régis Peffault ^a,b   Robin, Marie ^a   Krishnamoorthy, Rajagopal ^c   Toubert, Antoine ^a   Charron, Dominique ^a   Socié, Gérard ^a,b   Tamouza, Ryad ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Acute gvhd; Hematopoietic stem cell transplantation; HLA G polymorphism

Indexed keywords

EID: 84872122227     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00074     Document Type: Article

References (40)

1. Bainbridge, D. R., Ellis, S. A., and Sargent, I. L. (2000). HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J. Reprod. Immunol 48,17-26.
2. ! untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun. 11, 134-141.
3. Chen,X.Y.,Yan,W. H.,Lin,A.,Xu,H.H., Zhang, J. G., and Wang, X. X. (2008). The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 72, 335-341.
4. Chiusolo, P., Bellesi, S., Piccirillo, N., Giammarco, S., Marietti, S., De Ritis, D., Metafuni, E., Stignani, M., Baricordi, O. R., Sica, S., Leone, G., and Rizzo, R. (2011). The role of HLA-G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis. Bone Marrow Transplant. doi:10.1038/bmt.2011.40. [Epub ahead of print].
5. Cox, D. R. (1972). Regression models and life tables (with discussion). J. R. Stat. Soc. Series B Stat. Methodol. 34,187.
6. Crispim, J. C., Duarte, R. A., Soares, C P., Costa, R., Silva, J. S., Mendes-Júnior, C. T., Wastowski, I. J., Fag-gioni, L. P., Saber, L. T., and Donadi, E. A. (2008a). Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl. Immunol. 18, 361-367.
7. Crispim, J. C, Mendes-Junior, C. T., Wastowski, I. J., Costa, R., Castelli, E. C, Saber, L. T., and Donadi, E. A. (2008b). Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome. Tissue Antigens 71, 35-41.
8. Dickinson, A. M., and Charron, D. (2005). Non-HLA immunogenetics in hematopoietic stem cell transplantation. Curr. Opin. Immunol. 17, 517-525.
9. Ferrara, J. L., Levine, J. E., Reddy, P., and Holler, E. (2009). Graft-versus-host, disease. Lancet 373, 1550.
10. Fine, J. P., and Gray, R. J. (1999). A proportional hazards model for the sub distribution of a competing risk. JASA 94, 496.
11. Glucksberg, H., Storb, R., Fefer, A., Buckner, C. D., Neiman, P. E., Clift, R. A., Lerner, K. G., and Thomas, E. D (1974). Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18,295-304.
12. Hviid, T.V.,Hylenius,S.,Rørbye, C,and Nielsen, L. G. (2003). HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55, 63-79.
13. John, S. W., Weitzner, G., Rozen, R., and Scriver, C. R. (1991). A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res. 19, 408.
14. La Nasa, G., Littera, R., Locatelli, F., Lai, S., Alba, F., Caocci, G., Lisini, D., Nesci, S., Vacca, A., Piras, E., Bernardo, M. E., Di Cesare-Merlone, A., Orrù, S., and Carcassi, C. (2007). The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia. Br. J. Haematol. 139,284-288.
15. Larsen, M. H., and Hviid, T. V. (2009). Human leukocyte antigen-G polymorphism in relation to expression, function, and disease. Hum. Immunol. 70, 1026-1034.
16. Larsen, M. H., Hylenius, S., Andersen, A. M., and Hviid, T. V. (2010). The 3'-untranslated region of the HLA-G gene in relation to preeclampsia: revisited. Tissue Antigens 75, 253-261.
17. Le Maux, A., Noël, G., Birebent, B., Gros-set, J. M., Vu, N., De Guibert, S., Bernard, M., Semana, G., and Amiot, L. (2008). Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells. Clin. Exp. Immunol. 152, 50-56.
18. Le Rond, S., Azéma, C, Krawice-Radanne, I., Durrbach, A., Guet-tier, C, Carosella, E. D., and Rouas-Freiss, N. (2006). Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells.J. Immunol. 176, 3266-3276.
19. Lila, N., Amrein, C, Guillemain, R., Chevalier, P., Latremouille, C, Fabi-ani, J. N., Dausset, J., Carosella, E. D., and Carpentier, A. (2002). Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105, 194-1954.
20. Lila, N., Carpentier, A., Amrein, C, Khalil-Daher, I., Dausset, J., and Carosella, E. D. (2000). Implication of HLA-G molecule in heart-graft acceptance. Lancet 355,2138.
21. Menier, C., Rabreau, M., Challier, J. C., Le Discorde, M., Carosella, E. D., and Rouas-Freiss, N. (2004). Ery-throblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 104, 3153-3160.
22. Messina, C., Faraci, M., de Fazio, V., Dini, G., Calò, M. P., and Calore, E. (2008). Prevention and treatment of acute GvHD. Bone Marrow Transplant. 41, S65.
23. O'Brien, M., McCarthy, T., Jenkins, D., Paul, P., Dausset, J., Carosella, E. D., and Moreau, P. (2001). Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell. Mol. Life Sci. 58, 1943-1949.
24. Paul, P., Cabestre, F. A., Ibrahim, E. C., Lefebvre, S., Khalil-Daher, I.,Vazeux, G., Quiles, R. M., Bermond, F., Daus-set, J., and Carosella, E. D. (2000). Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum. Immunol. 61, 1138-1149.
25. Petersdorf, E. W., Malkki, M., Goo-ley, T. A., Martin, P. J., and Guo, Z. (2007). MHC haplotype matching for unrelated hematopoi-etic cell transplantation. PLoS Med. 4, e8. doi:10.1371/journal.pmed.00 40008
26. Piancatelli, D., Maccarone, D., Liber-atore, G., Parzanese, I., Clemente, K., Azzarone, R., Pisani, F., Famu-lari, A., and Papola, F. (2009). HLA-G 14-bp insertion/deletion polymorphism in kidney transplant patients with metabolic complications. Transplant. Proc. 41, 1187-1188.
27. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H. G., Beatty, P., Hows, J., and Thomas, E. D. (1995). 1994 Consensus conference on acute GVHDgrading.BoneMarrowTrans-plant. 15, 825-828.
28. Reddy, P., and Ferrara, J. L. (2003). Immunobiology of acute graft-versus-host disease. Blood Rev. 17, 187-194.
29. Ristich, V., Zhang, W., Liang, S., and Horuzsko, A. (2007). Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells. Hum. Immunol. 68, 264-271.
30. Rizzo, R., Hviid, T. V., Govoni, M., Padovan, M., Rubini, M., Mel-chiorri,L., Stignani, M., Carturan, S., Grappa, M. T., Fotinidi, M., Ferretti, S., Voss, A., Laustrup, H., Junker, P., Trotta, F., and Baricordi, O. R. (2008). HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 71, 520-529.
31. Rocha, V., Franco, R. F., Porcher, R., Bittencourt, H., Silva, W. A. Jr., Latouche, A., Devergie, A., Esperou, H., Ribaud, P., Socie, G., Zago, M. A., and Gluckman, E. (2002). Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 100,3908-3912.
32. Rouas-Freiss, N., Marchal, R. E., Kirszenbaum, M., Dausset, J., and Carosella, E. D. (1997). The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc. Natl. Acad. Sci. U.S.A. 94, 5249-5254.
33. Rousseau, P., Le Discorde, M., Mouil-lot, G., Marcou, C, Carosella, E. D., and Moreau, P. (2003). The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum. Immunol. 64, 1005-1010.
34. Socié, G., and Blazar, B. R. (2009). Acute graft-versus-host disease; from the bench to the bedside. Blood 114, 4327-4336.
35. Tan, Z., Randall, G., Fan, J., Camoretti-Mercado, B., Brockman-Schneider, R., Pan, L., Solway, J., Gern, J. E., Lemanske, R. F., Nicolae, D., and Ober, C. (2007). Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am. J. Hum. Genet. 81, 829-834.
36. Tripathi, P., Abbas, A., Naik, S., and Agrawal, S. (2004). Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 64, 706-710.
37. Twito, T., Joseph, J., Mociornita, A., Rao, V., Ross, H., and Delgado, D. H. (2011). The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. J. Heart Lung Transplant. 30, 778-782.
38. Veit, T. D., and Chies, J. A. (2009). Tolerance versus immune response -microRNAs as important elements in the regulation of the HLA-G gene expression. Transpl. Immunol. 20, 229-231.
39. Wiendl, H., Mitsdoerffer, M., Hofmeis-ter, V., Wischhusen, J., Borne-mann, A., Meyermann, R., Weiss, E. H., Melms, A., and Weller, M. (2002). A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J. Immunol 168, 4772-4780.
40. ;-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol. Hum. Reprod. 14, 649-653.